F1CHAPTER ISCOPE AND DEFINITIONS
Annotations:
Amendments (Textual)
F1Article 1Subject matter and scope
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
F1Article 2Definitions
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
F1Article 3Amendment of certain definitions
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
F1Article 4Regulatory status of products
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Regulation revoked (31.12.2020) by The Medical Devices Regulations 2002 (S.I. 2002/618), reg. 4O (with savings and transitional provisions for N.I. in reg. 3ZA) (as amended by S.I. 2019/791, regs. 1(1), 3(7) and by S.I. 2020/1478, regs. 1(3), Sch. 2 para. 2; and as amended (27.7.2021) by The Medical Devices (Northern Ireland Protocol) Regulations 2021 (S.I. 2021/905), regs. 1(2), 4, 32); 2020 c. 1, Sch. 5 para. 1(1))